270 related articles for article (PubMed ID: 36331784)
1. In silico identification of potential inhibitors of vital monkeypox virus proteins from FDA approved drugs.
Sahoo AK; Augusthian PD; Muralitharan I; Vivek-Ananth RP; Kumar K; Kumar G; Ranganathan G; Samal A
Mol Divers; 2023 Oct; 27(5):2169-2184. PubMed ID: 36331784
[TBL] [Abstract][Full Text] [Related]
2. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
Sib Tul Hassan Shah S; Naeem I
J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
[TBL] [Abstract][Full Text] [Related]
3. Identification of
Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; MartÃnez-Sobrido L
Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
[TBL] [Abstract][Full Text] [Related]
4. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762
[TBL] [Abstract][Full Text] [Related]
5. Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study.
Lam TP; Tran VH; Mai TT; Lai NV; Dang BN; Le MT; Tran TD; Trinh DT; Thai KM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232872
[TBL] [Abstract][Full Text] [Related]
6. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks.
Islam MR; Hossain MJ; Roy A; Hasan AHMN; Rahman MA; Shahriar M; Bhuiyan MA
Health Sci Rep; 2022 Sep; 5(5):e798. PubMed ID: 36032515
[TBL] [Abstract][Full Text] [Related]
7. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel potential inhibitors of monkeypox virus thymidine kinase using molecular docking, molecular dynamics simulation and MM/PBSA methods.
Abdizadeh T
Mol Divers; 2023 Jul; ():. PubMed ID: 37462851
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses.
Wang J; Shahed-Ai-Mahmud M; Chen A; Li K; Tan H; Joyce R
J Med Chem; 2023 Apr; 66(7):4468-4490. PubMed ID: 36961984
[TBL] [Abstract][Full Text] [Related]
10. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
[TBL] [Abstract][Full Text] [Related]
11. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From?
Tiecco G; Degli Antoni M; Storti S; Tomasoni LR; Castelli F; Quiros-Roldan E
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146705
[TBL] [Abstract][Full Text] [Related]
12. Antivirals against monkeypox infections.
Chiem K; Nogales A; Lorenzo M; Vasquez DM; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Mart Nez-Sobrido L
bioRxiv; 2023 Apr; ():. PubMed ID: 37131608
[TBL] [Abstract][Full Text] [Related]
13. A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus.
Hossain FMA; Bappy MNI; Robin TB; Ahmad I; Patel H; Jahan N; Rabbi MGR; Roy A; Chowdhury W; Ahmed N; Prome AA; Rani NA; Khan P; Zinnah KMA
J Biomol Struct Dyn; 2024 Aug; 42(12):6091-6107. PubMed ID: 37403283
[TBL] [Abstract][Full Text] [Related]
14. Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach.
Akash S; Hossain A; Hossain MS; Rahman MM; Ahmed MZ; Ali N; Valis M; Kuca K; Sharma R
Front Cell Infect Microbiol; 2023; 13():1157627. PubMed ID: 37033493
[TBL] [Abstract][Full Text] [Related]
15. Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach.
Sahu A; Gaur M; Mahanandia NC; Subudhi E; Swain RP; Subudhi BB
Comput Biol Med; 2023 Jul; 161():106971. PubMed ID: 37211001
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules.
Arasu MV; Vijayaragavan P; Purushothaman S; Rathi MA; Al-Dhabi NA; Gopalakrishnan VK; Choi KC; Ilavenil S
J Infect Public Health; 2023 May; 16(5):784-791. PubMed ID: 36958173
[TBL] [Abstract][Full Text] [Related]
17.
Lokhande KB; Shrivastava A; Singh A
J Biomol Struct Dyn; 2023; 41(23):14259-14274. PubMed ID: 36841550
[TBL] [Abstract][Full Text] [Related]
18. A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus.
Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Kumar GS; Dubey A; Dwivedi VD; Azhar EI
Sci Rep; 2023 Sep; 13(1):14570. PubMed ID: 37666979
[TBL] [Abstract][Full Text] [Related]
19. In Silico Repurposed Drugs against Monkeypox Virus.
Lam HYI; Guan JS; Mu Y
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014515
[TBL] [Abstract][Full Text] [Related]
20. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
